TEDD University Visit: EPFL AGORA Translational Cancer Research Center

15. November 2022

The EPFL Bioengineering and Organoids platform of the AGORA Cancer Research Center, located in Lausanne, is hosting the next visit event of our TEDD network.

EVENT FOCUS

About AGORA
Founded by ISREC Foundation in 2018, AGORA Cancer Research Center represents a collective effort for the fight against cancer. It results from a partnership between major actors of the Lemanic area: Vaud University Hospital (CHUV), Lausanne University (UNIL), Swiss Federal Institute of Technology Lausanne (EPFL), University Hospitals of Geneva (HUG) and Geneva University (UNIGE).

The AGORA multidisciplinary community gathers cancer biologists, clinicians, bio-informaticians & bioengineers.This integrated & collaborative ecosystem enables to carry out translational development of new therapeutic strategies to fight cancer.

The visit
This event will showcase the AGORA translational research environment and the available infrastructure for bioengineering and organoids research. Scientific talks will present you concrete examples of applications towards clinical translation. A tour will guide you through the AGORA building and core facilities. Also, a dedicated visit of the new Bioengineering & Organoids platform (EPFL) will expose you to the on-site expertise in advanced 3D cell model, microfluidics, and automation.

Watch a video about AGORA

DATE

15^th November 2022

PROGRAM(PDF 2,2 MB)

THIS EVENT IS FULLY BOOKED

ORGANIZATION

Gaspard Pardon, AGORA

François Signorino-Gelo, AGORA

Markus Rimann, TEDD

Katarzyna Kopanska, TEDD

COST